AB 2030 restricts covered diet supplement sales to minors
Oct 4, 2026 edition · GC-2026-0254 · Published 2026-10-04 · Version 2 · Final
AB 2030 restricts sale and delivery of qualifying nonprescription diet pills and weight-loss or muscle-building supplements to people under 18. Coverage turns on product representation and statutory definitions, with separate remote-sale verification methods and a prescription exception.
What happened
California enacted AB 2030 on September 28, adding Health and Safety Code section 109030. A person may not sell, offer or give away as a retail or wholesale promotion a covered over-the-counter diet pill or dietary supplement for weight loss or muscle building to a person under 18 in California. The definitions focus on products labelled, marketed or otherwise represented for those purposes and include retail pharmacies and remote vendors. Retail establishments face the specified valid-identification check, and the text permits limiting access to prevent unauthorized purchases. Courts may consider ingredients, claims, imagery, grouping and store or online categorization when evaluating a product’s represented purpose. The enactment is the event reported here; the applicable commencement of these provisions must be confirmed separately.
Delivery sellers must not accept an order without either or both of the specified verification routes: checking the purchaser’s name, date of birth and residential address against an eligible independent database, or using shipment requiring an adult signature and government photographic identification. The verification database cannot be controlled or altered by the seller. The section excludes a person under 18 with a prescription for the covered pill or supplement and does not apply to adults. Public officials may seek injunctions and civil penalties up to $500 per violation, with prevailing-plaintiff fees and cumulative remedies. The product and prescription limits matter before extending a retail rule to clinical treatment.
Scope and timing
- Authority status
- Final
- Applicability
- Potentially applicable
- Audience
- Health systems, Provider networks, Health-tech
- Jurisdiction
- California
Why it matters
A pharmacy’s shelf placement, claims and online tags can affect product classification alongside ingredients. Remote order acceptance and delivery controls may need different evidence, and a general age prompt does not necessarily establish either statutory verification route.
Recommended action
Confirm the applicable commencement before treating the new provisions as current duties. Prepare the following for implementation at that commencement: Classify covered products and review labels, displays and online representations. Prepare retail identification and remote verification controls, including independence of any database and evidence of adult delivery. Have counsel apply the prescription exception and keep unrelated prescription treatment outside the rule’s product scope.
Sources
- AB2030 enacted final textOfficial · California Legislature · 2026-09-28 · Source review 2026-10-05
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Compliance Sweep report →